Complementary and alternative medicine in major depressive disorder: The American psychiatric association task force report

Journal of Clinical Psychiatry

Volumn 71, Issue 6, 2010, Pages 669-681

  Freeman, Marlene P ^a   Fava, Maurizio ^a   Lake, James ^b   Trivedi, Madhukar H ^c   Wisner, Katherine L ^a   Mischoulon, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Southwestern Medical Center ^*

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FLUOXETINE; FOLIC ACID; HYPERICUM PERFORATUM EXTRACT; OMEGA 3 FATTY ACID; S ADENOSYLMETHIONINE;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; CONSTIPATION; DIZZINESS; DRUG EFFICACY; EXERCISE; HUMAN; HYPERICUM PERFORATUM; INSOMNIA; MAJOR DEPRESSION; MEDLINE; NAUSEA; NERVOUSNESS; PHOTOTHERAPY; PRIORITY JOURNAL; PSYCHOTHERAPY; PSYCINFO; SIDE EFFECT; SWEATING; SYSTEMATIC REVIEW; XEROSTOMIA;

ACUPUNCTURE THERAPY; ADVISORY COMMITTEES; COMPLEMENTARY THERAPIES; DEPRESSIVE DISORDER, MAJOR; FATTY ACIDS, OMEGA-3; HERBAL MEDICINE; HUMANS; HYPERICUM; MEDITATION; METHIONINE; PHOTOTHERAPY; PSYCHIATRY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 77953789279     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10cs05959blu     Document Type: Article

References (103)

1. National Center for Complementary and Alternative Medicine, National Institutes of Health. What Is Complementary and Alternative Medicine? NCCAM Publication No. D156. Bethesda, MD: National Center for Complementary and Alternative Medicine; 2002.
2. Barnes PM, Bloom B, Nahin R. Complementary and Alternative Medicine Use Among Adults and Children: United States 2007. National Health Statistics Reports: No 12. Hyattsville, MD: National Center for Health Statistics; 2008.
3. Druss BG, Rosenheck RA. Use of practitioner-based complementary therapies by persons reporting mental conditions in the United States. Arch Gen Psychiatry. 2000;57(7):708-714.
4. Simon GE, Cherkin DC, Sherman KJ, et al. Mental health visits to complementary and alternative medicine providers. Gen Hosp Psychiatry. 2004;26(3):171-177. (Pubitemid 38581921)
5. Kessler RC, Soukup J, Davis RB, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158(2):289-294. (Pubitemid 32116527)
6. Elkins G, Rajab MH, Marcus J. Complementary and alternative medicine use by psychiatric inpatients. Psychol Rep. 2005;96(1):163-166. (Pubitemid 40405975)
7. Unützer J, Klap R, Sturm R, et al. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry. 2000; 157(11):1851-1857.
8. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54(3):438-463.
9. Kris-Etherton PM, Harris WS, Appel LJ. AHA Nutrition Committee. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23(2):151-152. (Pubitemid 36231919)
10. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954-1967.
11. Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006;163(6):969-978. (Pubitemid 44464482)
12. Lin PY, Su KP. A meta-analytic review of double-blind, placebocontrolled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056-1061.
13. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59(10):913-919.
14. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159(3):477-479. (Pubitemid 34184747)
15. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13(4):267-271.
16. Silvers KM, Woolley CC, Hamilton FC, et al. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids. 2005;72(3):211-218. (Pubitemid 40139086)
17. Grenyer BF, Crowe T, Meyer B, et al. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(7):1393-1396.
18. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160(5):996-998. (Pubitemid 41079588)
19. Mischoulon D, Papakostas GI, Dording CM, et al. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry. 2009;70(12):1636-1644.
20. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163(6):1098-1100. (Pubitemid 44464498)
21. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry. 2008;42(3):192-198. (Pubitemid 351234188)
22. Freeman MP. Complementary and alternative medicine for perinatal depression. J Affect Disord. 2009;112(1-3):1-10.
23. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother. 2004;38(1):50-52.
24. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dosefinding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645.
25. Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313(7052):253-258. (Pubitemid 26254730)
26. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA. 2001;285(15):1978-1986.
27. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287(14):1807-1814.
28. Lecrubier Y, Clerc G, Didi R, et al. Efficacy of St John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry. 2002;159(8):1361-1366. (Pubitemid 34832718)
29. Fava M, Alpert J, Nierenberg AA, et al. A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol. 2005;25(5):441-447. (Pubitemid 41368366)
30. Roby CA, Anderson GD, Kantor E, et al. St John's wort: effect on CYP3A4 activity. Clin Pharmacol Ther. 2000;67(5):451-457. (Pubitemid 30327483)
31. Mannel M. Drug interactions with St John's wort: mechanisms and clinical implications. Drug Saf. 2004;27(11):773-797. (Pubitemid 39243561)
32. Mischoulon D, Fava M. Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr. 2002;76(supp): 1158S-1161S. (Pubitemid 35244695)
33. Bottiglieri T, Godfrey P, Flynn T, et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry. 1990;53(12):1096-1098.
34. Rosenbaum JF, Fava M, Falk WE, et al. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990;81(5):432-436.
35. Spillman M, Fava M. The role of ademetionine (S-adenosyl-methionine; SAMe) in the treatment of psychiatric disorders. CNS Drugs. 1996;6:416.
36. Agency for Healthcare Research and Quality. S-adenosyl-L-methionine (SAMe) for depression, osteoarthritis, and liver disease. August 2002. http://www.ahrq.gov/clinic/tp/sametp.htm.
37. Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand suppl. 1994;154:7-14. (Pubitemid 24210857)
38. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr. 2002;76(suppl):1172S-1176S.
39. Pancheri P, Scapicchio P, Chiaie RD. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L- methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Int J Neuropsychopharmacol. 2002;5(4):287-294.
40. Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-l-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol. 2004;24(6):661-664.
41. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. 2000;60(2):121-130.
42. Kelly CB, McDonnell AP, Johnston TG, et al. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol. 2004;18(4):567-571.
43. Guaraldi GP, Fava M, Mazzi F, et al. An open trial of methyltetrahydrofolate in elderly depressed patients. Ann Clin Psychiatry. 1993;5(2):101-105.
44. Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving major depression in chronic alcoholics? a hypothesis of treatment. Curr Ther Res. 1994;55(5):559-568.
45. Passeri M, Cucinotta D, Abate G, et al. Oral 5-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano). 1993;5(1):63-71.
46. Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990;336(8712):392-395. (Pubitemid 20252436)
47. Alpert JE, Mischoulon D, Rubenstein GE, et al. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry. 2002;14(1):33-38. (Pubitemid 34538830)
48. Coppen A, Chaudhry SSC, Swade C. Folic acid enhances lithium prophylaxis. J Affect Disord. 1986;10(1):9-13. (Pubitemid 16109820)
49. Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72-80.
50. Eastman CI, Young MA, Fogg LF, et al. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry. 1998;55(10):883-889. (Pubitemid 28465777)
51. Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry. 1998;55(10):875-882. (Pubitemid 28465776)
52. Lewy AJ, Sack RL, Singer CM, et al. The phase shift hypothesis for bright light's therapeutic mechanism of action: theoretical considerations and experimental evidence. Psychopharmacol Bull. 1987;23(3):349-353.
53. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656-662.
54. Lam RW, Levitt AJ, Levitan RD, et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry. 2006;163(5):805-812.
55. Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev. 2004;(2):CD004050.
56. Even C, Schröder CM, Friedman S, et al. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord. 2008;108(1-2):11-23. (Pubitemid 351418015)
57. Goel N, Terman M, Terman JS, et al. Controlled trial of bright light and negative air ions for chronic depression. Psychol Med. 2005;35(7):945-955. (Pubitemid 41015693)
58. Oren DA, Wisner KL, Spinelli M, et al. An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry. 2002;159(4):666-669. (Pubitemid 34274954)
59. Epperson CN, Terman M, Terman JS, et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry. 2004;65(3):421-425.
60. Martiny K, Lunde M, Undén M, et al. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatr Scand. 2005;112(2):117-125. (Pubitemid 41003190)
61. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10(8):647-663. (Pubitemid 41232548)
62. Terman M, Terman JS. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry. 1999;60(11):799-808, quiz 809.
63. Wirz-Justice A, Benedetti F, Terman M. Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy. Basel, Switzerland: Karger; 2009.
64. Mukaino Y, Park J, White A, et al. The effectiveness of acupuncture for depression - a systematic review of randomised controlled trials. Acupunct Med. 2005;23(2):70-76. (Pubitemid 40978885)
65. Smith CA, Hay PP. Acupuncture for depression. Cochrane Database Syst Rev. 2005;(2):CD004046.
66. Leo RJ, Ligot JS Jr. A systematic review of randomized controlled trials of acupuncture in the treatment of depression. J Affect Disord. 2007;97(1-3):13-22. (Pubitemid 44937429)
67. Wang H, Qi H, Wang BS, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials? J Affect Disord. 2008;111(2-3):125-134.
68. Vincent C. The safety of acupuncture. BMJ. 2001;323(7311):467-468.
69. Allen JB, Schnyer RN, Hitt SK. The efficacy of acupuncture in the treatment of major depression in women. Psychol Sci. 1998;9(5):397-401. (Pubitemid 128150590)
70. Halbreich U. Systematic reviews of clinical trials of acupuncture as treatment for depression: how systematic and accurate are they? CNS Spectr. 2008;13(4):293-294, 299-300. (Pubitemid 351656250)
71. Luo H, Meng F, Jia Y, et al. Clinical research on the therapeutic effect of the electro-acupuncture treatment in patients with depression. Psychiatry Clin Neurosci. 1998;52(suppl):S338-S340. (Pubitemid 128676357)
72. Röschke J, Wolf C, Müller MJ, et al. The benefit from whole body acupuncture in major depression. J Affect Disord. 2000;57(1-3):73-81.
73. Manber R, Schnyer RN, Allen JJ, et al. Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord. 2004;83(1):89-95.doi:10.1016/ j.jad.204.05.09 PubMed (Pubitemid 39488395)
74. Allen JJ, Schnyer RN, Chambers AS, et al. Acupuncture for depression: a randomized controlled trial. J Clin Psychiatry. 2006;67(11):1665-1673. (Pubitemid 44955145)
75. Manber R, Schnyer RN, Lyell D, et al. Acupuncture for depression during pregnancy: a randomized controlled trial. Obstet Gynecol. 2010;115(3):511-520.
76. Derry CJ, Derry S, McQuay HJ, et al. Systematic review of systematic reviews of acupuncture published 1996-2005. Clin Med. 2006;6(4):381-386.
77. Linde K, Allais G, Brinkhaus B, et al. Acupuncture for tension-type headache. Cochrane Database Syst Rev. 2009;(1):CD007587.
78. Linde K, Allais G, Brinkhaus B, et al. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;(1):CD001218.
79. Galper DI, Trivedi MH, Barlow CE, et al. Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc. 2006;38(1):173-178. (Pubitemid 43062974)
80. Wise LA, Adams-Campbell LL, Palmer JR, et al. Leisure time physical activity in relation to depressive symptoms in the Black Women's Health Study. Ann Behav Med. 2006;32(1):68-76.
81. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta- regression analysis of randomised controlled trials. BMJ. 2001;322(7289):763-767.
82. Sjösten N, Kivelä SL. The effects of physical exercise on depressive symptoms among the aged: a systematic review. Int J Geriatr Psychiatry. 2006;21(5):410-418. (Pubitemid 43757767)
83. Dunn AL, Trivedi MH, Kampert JB, et al. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005;28(1):1-8. (Pubitemid 40051319)
84. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587-596. (Pubitemid 47469807)
85. Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159(19):2349- 2356.
86. Babyak M, Blumenthal JA, Herman S, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62(5):633-638.
87. Martinsen EW, Medhus A, Sandvik L. Effects of aerobic exercise on depression: a controlled study. Br Med J (Clin Res Ed). 1985;291(6488):109. (Pubitemid 15068726)
88. Veale D, Le Fevre K, Pantelis C, et al. Aerobic exercise in the adjunctive treatment of depression: a randomized controlled trial. J R Soc Med. 1992;85(9):541-544.
89. Dimeo F, Bauer M, Varahram I, et al. Benefits from aerobic exercise in patients with major depression: a pilot study. Br J Sports Med. 2001;35(2):114-117. (Pubitemid 32275777)
90. Mather AS, Rodriguez C, Guthrie MF, et al. Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. Br J Psychiatry. 2002;180(5):411-415. (Pubitemid 34499335)
91. Trivedi MH, Greer TL, Grannemann BD, et al. Exercise as an augmentation strategy for treatment of major depression. J Psychiatr Pract. 2006;12(4):205-213. (Pubitemid 44180543)
92. Trivedi MH, Greer TL, Grannemann BD, et al. TREAD: treatment with exercise augmentation for depression: study rationale and design. Clin Trials. 2006;3(3):291-305. (Pubitemid 44098067)
93. Segal ZV, Williams JMG, Teasdale J. Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse. New York, NY: Guilford Press; 2002.
94. Kabat-Zinn J. Full Catastrophe Living: The Program of the Stress Reduction Clinic at the University of Massachusetts Medical Center. New York, NY: Delta; 1990.
95. Beck AT, Rush AJ, Shaw BF, et al. Cognitive Therapy for Depression. New York, NY: Guilford Press; 1979.
96. Coelho HF, Canter PH, Ernst E. Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. J Consult Clin Psychol. 2007;75(6):1000-1005.
97. Eisendrath SJ, Delucchi K, Bitner R, et al. Mindfulness-based cognitive therapy for treatment-resistant depression: a pilot study. Psychother Psychosom. 2008;77(5):319-320.
98. Cuijpers P, van Straten A, Warmerdam L. Problem solving therapies for depression: a meta-analysis. Eur Psychiatry. 2007;22(1):9-15. (Pubitemid 46162183)
99. Ryff CD. In the eye of the beholder: views of psychological well-being among middle-aged and older adults. Psychol Aging. 1989;4(2):195-201.
100. Fava GA. Well-being therapy: conceptual and technical issues. Psychother Psychosom. 1999;68(4):171-179.
101. Fava GA, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998;55(9):816-820.
102. Judd LL, Paulus MP, Zeller P. The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Arch Gen Psychiatry. 1999;56(8):764-765.
103. Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161(10):1872-1876.